ANTX

Conviction 100HealthcareScan · Mon, Aug 10, 2026

ANTX$5.92-0.17%

ResistanceSupportVol 14Insider sell

Vol MA14 209.88K

May 11May 28Jun 16Jul 6Jul 23Aug 10

AN2 Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.an2therapeutics.com ↗

Price5.92

Change-0.17%

Gap+0.00%

Rel volume2.40×

Avg volume202.28K

Avg $ vol1.08M

SMA 205.20

SMA 504.82

SMA 2002.94

Price vs 50+22.74%

Price vs 200+101.23%

MA stackbullish

50/200 cross—

Supertrendup · 4.83

RSI (14)68

MACD hist0.10

MACD cross—

Stoch %K / %D80 / 83

ADX (14)23

+DI / −DI26 / 11

RSI divergence—

MACD divergence—

ATR %+6.72%

ADR %7.57%

52w high6.08

52w low1.03

From 52w high-2.63%

Above 52w low+474.76%

New 52w highNo

SqueezeOff

Bollinger width37.71%

%B0.87

Donchian pos81.62%

Donchian high6.26

Donchian low4.41

AVWAP (52w high)4.86

vs AVWAP high+21.73%

AVWAP (52w low)4.51

vs AVWAP low+31.28%

OBV trendUp

Chaikin MF (20)0.11

Today vs 20d2.40×

Avg vol (14d)209.88K

Avg vol (20d)202.28K

Avg $ vol (20d)1.08M

Market cap213.22M

RS 3m (vs SPY)+23.22%

RS 6m (vs SPY)+445.32%

RS line new highNo

Trend template8/8

Technical rank95.3

1 week+6.09%

1 month+31.56%

3 months+32.74%

6 months+443.12%

1 year+448.15%

YTD+433.33%

P/E-6.06

P/B2.61

P/S—

P/FCF—

EPS-1.16

Div yield—

ROE-43.02%

ROA-40.20%

Debt/Eq—

Current15.73

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth31.46%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value159.73M

Revenue—

Net income-10.03M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.02M

Employees21

ListedFri, Mar 25, 2022

Free float25.94M

Float %72.2%

Short interest2.44M

Days to cover9.9d

Short volume46.3%

Squeeze score63 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank95.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.89

Support4.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANTX

All disclosures →

No recent disclosed trades by Congress in ANTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANTX · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Martin Patricia A. Director · Common Stock · 2026-07-10	Grant	766	—	2026-07-10	2026-07-10
Marks Gilbert Lynn Director · Common Stock · 2026-07-10	Grant	2.79K	—	2026-07-10	2026-07-10
Aziz Kabeer Director · Common Stock · 2026-07-10	Grant	2.85K	—	2026-07-10	2026-07-10
Eizen Joshua M See Remarks · Common Stock · 2026-07-08	Sell	5.95K	$25K	2026-07-08	2026-07-10
Williams Sarah Joanne Principal Accounting Officer · Common Stock · 2026-05-29	Sell	265	$1K	2026-05-29	2026-06-02
Aziz Kabeer Director · Common Stock · 2026-04-10	Grant	3.77K	$0	2026-04-10	2026-04-10
Marks Gilbert Lynn Director · Common Stock · 2026-04-10	Grant	3.77K	$0	2026-04-10	2026-04-10
Aziz Kabeer Director · Common Stock · 2026-04-10	Other	—	—	2026-04-10	2026-04-10
Martin Patricia A. Director · Common Stock · 2026-04-10	Grant	1.19K	$0	2026-04-10	2026-04-10

SEC filings

EDGAR filings in ANTX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.